Reproductive and Developmental Biology
A healthy life begins in the womb, so understanding what might go wrong in pregnancy and developing interventions to help will ultimately improve the health of society overall. "
Professor Phillip Bennett
Head of Division
The stage is set for a healthy pregnancy before conception and events during pregnancy can influence the whole of the rest of life. The quality of fetal life predicts not only pregnancy specific maternal disease, appropriate fetal growth, and early neonatal outcomes, but is a major contributor to the quality of health in adult life. The major complications of pregnancy; preterm birth, pre-eclampsia and fetal growth restrictions are major causes of childhood mortality and life-long morbidity. Pregnancy acts to uncover maternal predisposition to diseases such as diabetes and hypertension in later life, providing an opportunity to consider earlier interventions to improve population health.
Across 30 principal investigators (11 scientists and 19 clinician-scientists), the Institute of Reproductive and Developmental Biology has a portfolio of basic and translational research into fertility, stem cell biology, reproduction, pregnancy and childbirth, preterm labour, women’s cancer, and pregnancy after cancer treatment. We facilitate interdisciplinary collaborations between scientists and clinical academics to translate research of the highest quality into patient benefit, and to improve reproductive outcomes for women and the long-term health of them and their children.
Areas of Study
- Section of Fetal-Maternal Medicine (Professor Christoph Lees)
- Section of Glycosciences (Professor Ten Feizi)
- Section of Gynaecological Oncology (Dr Mara Kyrgiou)
- Section of Pregnancy, Parturition and Prematurity (Dr David MacIntyre)
- Section of Reproductive Medicine (Professor Kate Hardy)
The Division has a number of key facilities and centres: